Breast Cancer, Version 3.2018-Reference-Cited by-同舟云学术

Breast Cancer, Version 3.2018

Published:2019-02 Issue:2 Volume:17 Page:118-126
ISSN:1540-1405
Container-title:Journal of the National Comprehensive Cancer Network
language:
Short-container-title:

Author:

Goetz Matthew P.¹,Gradishar William J.²,Anderson Benjamin O.³,Abraham Jame⁴,Aft Rebecca⁵,Allison Kimberly H.⁶,Blair Sarah L.⁷,Burstein Harold J.⁸,Dang Chau⁹,Elias Anthony D.¹⁰,Farrar William B.¹¹,Giordano Sharon H.¹²,Goldstein Lori J.¹³,Isakoff Steven J.¹⁴,Lyons Janice⁴,Marcom P. Kelly¹⁵,Mayer Ingrid A.¹⁶,Moran Meena S.¹⁷,Mortimer Joanne¹⁸,O'Regan Ruth M.¹⁹,Patel Sameer A.¹³,Pierce Lori J.²⁰,Reed Elizabeth C.²¹,Rugo Hope S.²²,Sitapati Amy⁷,Smith Karen Lisa²³,Smith Mary Lou²⁴,Soliman Hatem²⁵,Telli Melinda L.⁶,Ward John H.²⁶,Young Jessica S.²⁷,Shead Dorothy A.²⁸,Kumar Rashmi²⁸

Affiliation:

1. 1Mayo Clinic Cancer Center;

2. 2Robert H. Lurie Comprehensive Cancer Center of Northwestern University;

3. 3University of Washington/Seattle Cancer Care Alliance;

4. 4Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute;

5. 5Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine;

6. 6Stanford Cancer Institute;

7. 7UC San Diego Moores Cancer Center;

8. 8Dana-Farber/Brigham and Women’s Cancer Center;

9. 9Memorial Sloan Kettering Cancer Center;

10. 10University of Colorado Cancer Center;

11. 11The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute;

12. 12The University of Texas MD Anderson Cancer Center;

13. 13Fox Chase Cancer Center;

14. 14Massachusetts General Hospital Cancer Center;

15. 15Duke Cancer Institute;

16. 16Vanderbilt-Ingram Cancer Center;

17. 17Yale Cancer Center/Smilow Cancer Hospital;

18. 18City of Hope National Medical Center;

19. 19University of Wisconsin Carbone Cancer Center;

20. 20University of Michigan Rogel Cancer Center;

21. 21Fred & Pamela Buffett Cancer Center;

22. 22UCSF Helen Diller Family Comprehensive Cancer Center;

23. 23The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;

24. 24Research Advocacy Network;

25. 25Moffitt Cancer Center;

26. 26Huntsman Cancer Institute at the University of Utah;

27. 27Roswell Park Comprehensive Cancer Center; and

28. 28National Comprehensive Cancer Network.

Abstract

These NCCN Guidelines Insights highlight the updated recommendations for use of multigene assays to guide decisions on adjuvant systemic chemotherapy therapy for women with hormone receptor–positive, HER2-negative early-stage invasive breast cancer. This report summarizes these updates and discusses the rationale behind them.

Publisher

Harborside Press, LLC

Subject

Oncology

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical considerations of CDK4/6 inhibitors in HER2 positive breast cancer;Frontiers in Oncology;2024-01-16

2. Research Electronic Data Capture (REDCap) in an outpatient oncology surgery setting to securely email, collect, and manage survey data;Journal of Advanced Nursing;2023-12-02

3. Prognostic value of axillary lymph node metastases in invasive lobular breast carcinoma;Journal of Gynecology Obstetrics and Human Reproduction;2023-12

4. CD24 May Serve as an Immunotherapy Target in Triple-Negative Breast Cancer by Regulating the Expression of PD-L1;Breast Cancer: Targets and Therapy;2023-12

5. MRI-derived extracellular volume as a biomarker of cancer therapy cardiotoxicity: systematic review and meta-analysis;European Radiology;2023-10-12